MANDY DE BRUIN: Open Payments
NPI 1033789672 · HARDEEVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 76 payments from 15 companies in 2025. Trend: 2023 $256 · 2024 $1,026 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $380 |
| Janssen Biotech, Inc. | 12 | $194 |
| Lilly USA, LLC | 10 | $166 |
| Ardelyx, Inc. | 5 | $109 |
| Intercept Pharmaceuticals, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| PFIZER INC. | 3 | $57 |
| Madrigal Pharmaceuticals | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
Products named: TREMFYA, OMVOH, RINVOQ, IBSRELA, LINZESS, OCALIVA, SKYRIZI, VIBERZI.
Industry payments across SC — which companies pay providers there.
